Photo by Markus Spiske on Unsplash
- As of June 22, 2026, Fomo closed a $75M Series B at a $550M valuation — roughly 4.7x above the $117M median post-money valuation for Series B rounds globally.
- Prosper AI grew revenue 5x in six months across 150,000+ providers, landing a $30M Series A led by a16z on June 22, 2026.
- Both companies run the same playbook: build an AI wedge that eliminates operational friction, prove pull-through expansion, then raise at a premium multiple.
- Precise, an adtech platform for programmatic and agentic media decisions, raised $7M in seed funding the same day — bringing NYC's total June 22 raise to $112M.
What Just Happened — Three NYC Rounds, One Underlying Thesis
625,000 traders. 17 employees. $4 billion in trading volume since a 2025 launch. Those numbers alone make Fomo's June 22, 2026 funding announcement worth stopping on — but Index Ventures' framing says more. The firm described the round as evidence that "On-Chain Trading Goes Mainstream," a positioning statement less about Fomo specifically and more about where institutional capital thinks retail crypto adoption is heading.
According to Google News, the AlleyWatch daily funding report for June 22, 2026 aggregated three distinct NYC startup announcements in a single digest: Fomo's $75M Series B led by Index Ventures with Union Square Ventures and Benchmark participating; Prosper AI's $30M Series A led by Andreessen Horowitz with Base10 Partners, Emergence Capital, Y Combinator, and Company Ventures; and Precise's $7M seed co-led by Blockchange Ventures and Lasagna, with Click Ventures and 3C Ventures joining. Together, they illustrate a unified 2026 VC thesis: back AI-native platforms that remove friction from complex, multi-step workflows — and price them aggressively when the unit economics hold.
The Mechanism — Social Trading as the Retail Crypto Wedge
Most crypto platforms scale headcount alongside user volume. Fomo inverted that ratio so aggressively it looks like a reporting error. As of June 22, 2026, the company onboards approximately 3,500 new users daily with just 17 total employees, and has accumulated 110 million social interactions since its 2025 launch.
The wedge is deliberate. By layering social trading features — copy-trade signals, community watchlists, real-time position sharing — on top of cross-chain infrastructure that handles bridge management and gas fee calculations automatically, Fomo collapsed the expertise barrier for first-time buyers. The clearest evidence: as of June 22, 2026, 68,000 first-time crypto purchasers used Apple Pay through the platform, accounting for approximately $25 million in purchases. That Apple Pay integration is the ICP-fit tell. Fomo isn't targeting DeFi power users; it's recruiting people who have never heard of a gas fee.
Chart: Fomo's $550M Series B valuation and $75M raise set against the global Series B median post-money valuation ($117M) and average raise ($27M) as of June 2026.
The premium reflects the insight. In my analysis, the $550M valuation is defensible if Fomo sustains its daily user growth and converts social engagement into recurring trading volume — two metrics that will determine whether this multiple holds at Series C. Call me cautiously optimistic on the first, skeptical on the second until the company publishes cohort retention data. For founders building in crypto or fintech, this is the pattern worth studying, not the headline number. As Smart Startup AI's Ethereum vs. Solana breakdown outlined, the infrastructure layer is maturing; the durable opportunity now sits in the UX layer built above it.
Why Prosper AI's 5x Revenue Growth Outshines the Round Size
Prosper AI's $30M Series A is smaller than Fomo's raise, but the underlying metrics arguably carry more weight from a unit-economics standpoint. As of June 22, 2026, the company has grown revenue 5x in six months, added 40+ healthcare organizations as customers, and expanded to 150,000+ providers across 50+ outpatient groups spanning 25+ medical specialties. Its integrations cover athenahealth, ModMed, Veradigm, ECW, and ImagineSoftware EHR systems — the kind of deep system-of-record connections that take years to negotiate and create durable switching costs once embedded.
Jay Rughani, a16z partner, was direct about the firm's conviction: "Prosper AI stood out because of the scope of their ambition, wanting to eliminate every administrative friction point between a patient and the care they need." But the more analytically interesting detail is the pull-through expansion pattern a16z cited: providers deploy Prosper AI for scheduling, then expand into insurance verification and billing. That sequential adoption — one wedge product expanding horizontally into adjacent workflow problems — is the compound startup playbook in its cleanest form. As of June 22, 2026, Prosper AI's platform powers $1.3B+ in patient care, a figure that makes the $30M raise look conservative rather than stretched.
Both companies reflect a broader 2026 VC environment shaped by AI infrastructure bets. As context, Q1 2026 produced $300B in global startup funding, and May 2026 saw Anthropic close a $50B Series H — the largest venture round in history. Against that backdrop, a $30M healthcare AI raise and a $75M crypto raise represent early-category bets on platform businesses, not lottery tickets. NYC's startup ecosystem — over 25,000 tech startups valued at $147B collectively as of June 2026 — is generating these deals at a consistent pace, reinforcing the city's position as the world's second-largest venture capital ecosystem.
The Founder Move for This Quarter
Three concrete steps emerge from the June 22 AlleyWatch report for founders building in adjacent spaces:
Both funded companies can answer, in one sentence, which specific friction point they eliminate and what the before/after looks like in measurable terms: trading volume generated, revenue cycles shortened, scheduling abandonment reduced. If your pitch deck doesn't contain a friction removal claim with a metric attached, that's the gap to close before the next investor conversation. In a market housing over 25,000 tech startups, vague "we improve X" framing doesn't survive first-round diligence.
a16z's investment rationale for Prosper AI explicitly named the pull-through pattern — scheduling leading to billing leading to insurance verification — as central to the conviction. That's not accidental product behavior; it's intentional land-and-expand architecture baked into the roadmap. Early founders should map their feature sequence so the wedge creates natural demand for the next adjacent workflow. The wedge gets you in the door; the platform keeps you at expansion-stage multiples.
Fomo's $550M valuation is a genuine outlier. The global Series B median post-money valuation sits at $117M as of June 2026; Fomo's round is 4.7x that figure. Building fundraise expectations around outlier rounds leads to misaligned dilution projections and strained investor conversations. For founders exploring venture capital for NYC startups specifically, the city's Venture for NYC program launched $184M across three funds — $40M early-stage, $102M for diverse managers, and $42M in accelerator partnerships — providing structured pathways beyond traditional VC for early-stage companies that aren't yet at outlier metrics.
Frequently Asked Questions
How does social trading work in crypto platforms like Fomo?
Social trading lets retail investors mirror the positions of more experienced traders in real time. On platforms like Fomo, this is layered on top of cross-chain infrastructure that handles bridge management and gas fee calculations automatically — removing the technical expertise barrier for first-time buyers. The approach appears to work: as of June 22, 2026, Fomo has attracted 625,000+ traders, processed 110 million social interactions, and recorded $4B in trading volume since its 2025 launch, with 68,000 first-time crypto purchasers onboarding through Apple Pay alone.
What is Series B funding and how does startup valuation work?
A Series B round (the second major institutional raise, following a Series A) typically occurs after a startup has proven initial product-market fit and needs capital to scale operations, engineering, or go-to-market. Valuation at Series B reflects investor expectations about future revenue trajectory, not current profitability. As of June 2026, the average Series B globally raises $27M at a median post-money valuation of $117M — which makes Fomo's $75M raise at a $550M post-money valuation a meaningful statistical outlier, not a typical benchmark.
How to get venture capital funding for a startup in NYC?
NYC remains the world's second-largest venture capital ecosystem as of June 2026, with over 25,000 tech startups valued at $147B collectively. Pathways include traditional VC outreach — Index Ventures, Union Square Ventures, Benchmark, and a16z all made NYC investments on June 22, 2026 alone — participation in accelerator programs (Y Combinator backed Prosper AI), and city-funded programs. The Venture for NYC initiative launched $184M across three dedicated funds: $40M targeting early-stage companies, $102M supporting diverse fund managers, and $42M channeled through accelerator partnerships.
How does AI automation help healthcare providers reduce administrative costs?
Healthcare AI platforms like Prosper AI automate the patient journey from initial scheduling through insurance verification and billing — tasks that traditionally require manual staff coordination across multiple disconnected software systems. By integrating directly with EHR platforms including athenahealth, ModMed, Veradigm, ECW, and ImagineSoftware, the platform eliminates handoff friction between systems. As of June 22, 2026, Prosper AI covers 150,000+ providers across 25+ medical specialties, has added 40+ healthcare organizations as customers, and has grown revenue 5x in six months — suggesting that deep EHR-native integration is the critical unlock for provider adoption at scale.
Disclaimer: This article is editorial commentary for informational purposes only and does not constitute financial, investment, or legal advice. No independent product testing was conducted. Research based on publicly available sources current as of June 22, 2026.